NL8203250A - Werkwijze voor de zuivering van riboflavine-5'-monofosfaat. - Google Patents
Werkwijze voor de zuivering van riboflavine-5'-monofosfaat. Download PDFInfo
- Publication number
- NL8203250A NL8203250A NL8203250A NL8203250A NL8203250A NL 8203250 A NL8203250 A NL 8203250A NL 8203250 A NL8203250 A NL 8203250A NL 8203250 A NL8203250 A NL 8203250A NL 8203250 A NL8203250 A NL 8203250A
- Authority
- NL
- Netherlands
- Prior art keywords
- fmn
- riboflavin
- column
- formula
- monophosphate
- Prior art date
Links
- FVTCRASFADXXNN-SCRDCRAPSA-N flavin mononucleotide Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-SCRDCRAPSA-N 0.000 title claims description 13
- 238000000034 method Methods 0.000 title claims description 8
- 238000000746 purification Methods 0.000 title description 4
- FVTCRASFADXXNN-UHFFFAOYSA-N flavin mononucleotide Natural products OP(=O)(O)OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-UHFFFAOYSA-N 0.000 claims description 13
- 150000001450 anions Chemical class 0.000 claims description 12
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 10
- 125000004432 carbon atom Chemical group C* 0.000 claims description 7
- 125000000217 alkyl group Chemical group 0.000 claims description 6
- 238000004587 chromatography analysis Methods 0.000 claims description 4
- 229920002845 Poly(methacrylic acid) Polymers 0.000 claims description 3
- 229920002125 Sokalan® Polymers 0.000 claims description 3
- 150000002148 esters Chemical class 0.000 claims description 3
- 239000004584 polyacrylic acid Substances 0.000 claims description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 34
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 17
- 229960002477 riboflavin Drugs 0.000 description 17
- 235000019192 riboflavin Nutrition 0.000 description 17
- 239000002151 riboflavin Substances 0.000 description 17
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 10
- 235000002639 sodium chloride Nutrition 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 239000007788 liquid Substances 0.000 description 8
- 150000002500 ions Chemical class 0.000 description 7
- 229920000137 polyphosphoric acid Polymers 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- 239000012535 impurity Substances 0.000 description 6
- 239000011780 sodium chloride Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 5
- 235000019253 formic acid Nutrition 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 4
- 239000011347 resin Substances 0.000 description 4
- 229920005989 resin Polymers 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 150000007942 carboxylates Chemical group 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 239000012458 free base Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 description 2
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 239000012736 aqueous medium Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 235000019162 flavin adenine dinucleotide Nutrition 0.000 description 2
- 239000011714 flavin adenine dinucleotide Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 150000004712 monophosphates Chemical class 0.000 description 2
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 2
- 230000000865 phosphorylative effect Effects 0.000 description 2
- 150000003287 riboflavins Chemical class 0.000 description 2
- FJTKLVBCDXULJP-UHFFFAOYSA-N 1-(dimethylamino)-3-phenylpropan-2-ol Chemical group CN(C)CC(O)CC1=CC=CC=C1 FJTKLVBCDXULJP-UHFFFAOYSA-N 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- 239000004971 Cross linker Substances 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 239000004280 Sodium formate Substances 0.000 description 1
- 206010047612 Vitamin B2 deficiency Diseases 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 125000005396 acrylic acid ester group Chemical group 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 229940100198 alkylating agent Drugs 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 201000007590 ariboflavinosis Diseases 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- IUNMPGNGSSIWFP-UHFFFAOYSA-N dimethylaminopropylamine Chemical compound CN(C)CCCN IUNMPGNGSSIWFP-UHFFFAOYSA-N 0.000 description 1
- XXBDWLFCJWSEKW-UHFFFAOYSA-N dimethylbenzylamine Chemical group CN(C)CC1=CC=CC=C1 XXBDWLFCJWSEKW-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- VWWQXMAJTJZDQX-UYBVJOGSSA-N flavin adenine dinucleotide Chemical compound C1=NC2=C(N)N=CN=C2N1[C@@H]([C@H](O)[C@@H]1O)O[C@@H]1CO[P@](O)(=O)O[P@@](O)(=O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C2=NC(=O)NC(=O)C2=NC2=C1C=C(C)C(C)=C2 VWWQXMAJTJZDQX-UYBVJOGSSA-N 0.000 description 1
- 229940093632 flavin-adenine dinucleotide Drugs 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 125000005397 methacrylic acid ester group Chemical group 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 208000004223 riboflavin deficiency Diseases 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- HLBBKKJFGFRGMU-UHFFFAOYSA-M sodium formate Chemical compound [Na+].[O-]C=O HLBBKKJFGFRGMU-UHFFFAOYSA-M 0.000 description 1
- 235000019254 sodium formate Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
- C07F9/65618—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system, e.g. flavins or analogues
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP13135581 | 1981-08-21 | ||
| JP56131355A JPS5832898A (ja) | 1981-08-21 | 1981-08-21 | リボフラビン−５′−モノ燐酸エステルの精製方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL8203250A true NL8203250A (nl) | 1983-03-16 |
Family
ID=15055984
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL8203250A NL8203250A (nl) | 1981-08-21 | 1982-08-19 | Werkwijze voor de zuivering van riboflavine-5'-monofosfaat. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US4476304A (fr) |
| JP (1) | JPS5832898A (fr) |
| CH (1) | CH652723A5 (fr) |
| DE (1) | DE3230895A1 (fr) |
| DK (1) | DK372082A (fr) |
| FR (1) | FR2511686B1 (fr) |
| GB (1) | GB2108505B (fr) |
| NL (1) | NL8203250A (fr) |
| SE (1) | SE445349B (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3810957A1 (de) * | 1988-03-31 | 1989-10-19 | Basf Ag | Verfahren zur reinigung von salzen des riboflavin-5'-phosphats, insbesondere von mononatrium-riboflavin-5'-phosphat |
| US5814672A (en) * | 1994-12-05 | 1998-09-29 | Mitsubishi Chemical Corporation | Strongly basic anion exchange resin and process for its production |
-
1981
- 1981-08-21 JP JP56131355A patent/JPS5832898A/ja active Pending
-
1982
- 1982-08-18 SE SE8204756A patent/SE445349B/sv not_active IP Right Cessation
- 1982-08-19 NL NL8203250A patent/NL8203250A/nl not_active Application Discontinuation
- 1982-08-19 DK DK372082A patent/DK372082A/da not_active Application Discontinuation
- 1982-08-19 DE DE3230895A patent/DE3230895A1/de not_active Withdrawn
- 1982-08-20 US US06/409,809 patent/US4476304A/en not_active Expired - Fee Related
- 1982-08-20 GB GB08224068A patent/GB2108505B/en not_active Expired
- 1982-08-20 FR FR8214417A patent/FR2511686B1/fr not_active Expired
- 1982-08-23 CH CH5002/82A patent/CH652723A5/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DK372082A (da) | 1983-02-22 |
| SE8204756D0 (sv) | 1982-08-18 |
| JPS5832898A (ja) | 1983-02-25 |
| FR2511686A1 (fr) | 1983-02-25 |
| CH652723A5 (de) | 1985-11-29 |
| GB2108505A (en) | 1983-05-18 |
| DE3230895A1 (de) | 1983-06-01 |
| US4476304A (en) | 1984-10-09 |
| SE445349B (sv) | 1986-06-16 |
| GB2108505B (en) | 1985-03-27 |
| FR2511686B1 (fr) | 1986-07-11 |
| SE8204756L (sv) | 1983-02-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0011435B1 (fr) | Procédé de purification d'interféron issu de fibroblaste humain | |
| EP0179608B1 (fr) | Complexes de technétium-99m avec des oxines de propylèneamines | |
| Kondo et al. | Structure of cadystin, the unit-peptide of cadmium-binding peptides induced in a fission yeast, Schizosaccharomyces pombe | |
| US4256631A (en) | Process for the preparation of immunoglobulin for intravenous administration | |
| Yamada et al. | The synthesis of a 5′-deoxyadenosylcobalamin-agarose adsorbent and its utility in the purification of ribonucleotide reductase | |
| JPH05117290A (ja) | ２−Ｏ−α−Ｄ−グルコピラノシル−Ｌ−アスコルビン酸高含有物の製造方法 | |
| JP2003321496A (ja) | 血清アルブミンの精製方法 | |
| NL8203250A (nl) | Werkwijze voor de zuivering van riboflavine-5'-monofosfaat. | |
| US4743621A (en) | Ester of acetyl carnitine, processes for its preparation and pharmaceutical compositions containing it | |
| JPH0556957B2 (fr) | ||
| US3058884A (en) | Process for purifying heparin | |
| US5463035A (en) | Process for purifying pentostatin | |
| JP3315158B2 (ja) | グルタチオンの精製法 | |
| JP2001026567A (ja) | シキミ酸の精製方法 | |
| JPS58103355A (ja) | タウリンの製造法 | |
| US3935185A (en) | Polynucleotides of poly(5-hydroxycytidylic acids) | |
| US3982002A (en) | Vincamine 2-ketoglutarate and compositions containing vincamine 2-ketoglutarate | |
| CN1046157A (zh) | 一种消瘤药——甲硝唑氨酸的合成方法 | |
| JPS5840472B2 (ja) | カリクレイン含有液中のキニン分解酵素の除去法 | |
| JPH10310610A (ja) | シアリルラクトース結合ポリスチレン誘導体及びその用途 | |
| EP0518706A2 (fr) | Agent inhibitant la prolifération de cellules tumorales animales ou humaines et procédé de sa fabrication | |
| Cadby et al. | The analysis of hematoporphyrin derivative | |
| EP0385686A2 (fr) | Composés | |
| SU777903A1 (ru) | Способ получени аминокислотного препарата дл парентерального питани | |
| JPS5821618B2 (ja) | 肉類罐詰蒸煮廃液からクレアチン類の単離方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A85 | Still pending on 85-01-01 | ||
| DNT | Communications of changes of names of applicants whose applications have been laid open to public inspection |
Free format text: MITSUBISHI KASEI CORPORATION |
|
| BV | The patent application has lapsed |